Lawrence M Alleva
CIK 1553053 · last filed 2026-08-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BFAM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2 WELLS AVE
NEWTON, MA 02459
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BFAM | Director | 13,336 | $51.97 | $693.1K | -$807.4K | 21 | 2026-06-05 |
| Mersana Therapeutics, Inc. (MRSN) Delisted | Director | 0 | $29.08 | $0 | $39.8K | 25 | 2026-01-06 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | Director | 130,764 | $0.06 | $7.6K | $34.3K | 7 | 2024-07-01 |
| Galera Therapeutics, Inc. (GRTX) Delisted | Director | 52 | $17.60 | $915 | $97.7K | 10 | 2023-07-05 |
| ASND | Director | 117,864 | $259.85 | $30.63M | $39.7K | 5 | 2019-07-03 |
| TESARO, Inc. (TSRO) Delisted | Director | 0 | — | — | $5.2K | 13 | 2019-01-22 |
| SYNLOGIC, INC. (MIRN) Delisted | Director | 4,025 | — | — | $0 | 2 | 2016-09-06 |
Recent Filings · Page 8 of 9
87 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-06-03 | TESARO, Inc. (TSRO) Delisted | Grant (A) | +1,480 | $0 | EDGAR |
| 2016-05-13 | BFAM | Grant (A) | +1,000 | $0 | EDGAR |
| 2015-10-06 | SYNLOGIC, INC. (MIRN) Delisted | Mixed | +4,025 | $0 | EDGAR |
| 2015-09-30 | — | Grant (A) | — | $0 | |
| 2015-06-03 | TESARO, Inc. (TSRO) Delisted | Grant (A) | +1,069 | $0 | EDGAR |
| 2015-05-13 | BFAM | Grant (A) | — | $0 | EDGAR |
| 2014-09-30 | TESARO, Inc. (TSRO) Delisted | Buy (P) | +1,100 | $28.8K | EDGAR |
| 2013-11-27 | BFAM | Buy (P) | +1,400 | $49.5K | EDGAR |
| 2013-08-01 | TESARO, Inc. (TSRO) Delisted | Buy (P) | +1,449 | $49.7K | EDGAR |
| 2013-06-05 | TESARO, Inc. (TSRO) Delisted | Grant (A) | +1,114 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.